0001209191-21-014749.txt : 20210226 0001209191-21-014749.hdr.sgml : 20210226 20210226162327 ACCESSION NUMBER: 0001209191-21-014749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 21689225 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Chief Accounting Officer Common Stock 2021-02-24 4 F 0 864 217.57 D 15964 D Common Stock 2021-02-25 4 S 0 244 211.80 D 15720 D Common Stock 2021-02-25 4 S 0 452 213.12 D 15268 D Common Stock 2021-02-25 4 S 0 258 214.32 D 15010 D Common Stock 2021-02-25 4 S 0 126 216.25 D 14884 D Common Stock 169 I 401(k) Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $211.80 (range $211.57 to $212.07). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $213.12 (range $212.82 to $213.79). Open market sales reported on this line occurred at a weighted average price of $214.32 (range $213.90 to $214.69). Open market sales reported on this line occurred at a weighted average price of $216.25 (range $215.79 to $216.76). /s/ Sabrina Yohai, Attorney-in-Fact 2021-02-26